Benitec Biopharma Inc. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported net loss was USD 5.95 million compared to USD 5.09 million a year ago. Basic loss per share from continuing operations was USD 2.76 compared to USD 7.98 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | -0.58% | -1.29% | +113.62% |
Apr. 25 | Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors | CI |
Apr. 18 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.62% | 17.89M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BNTC Stock
- News Benitec Biopharma Inc.
- Benitec Biopharma Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023